Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€111.50

€111.50

-1.020%
-1.2
-1.020%
€129.84
 
25.02.26 / Tradegate WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Transmedics Group Inc Stock

A loss of -1.020% shows a downward development for Transmedics Group Inc.
Transmedics Group Inc is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
As a result the target price of 129 € shows a slightly positive potential of 15.7% compared to the current price of 111.5 € for Transmedics Group Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Transmedics Group Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Transmedics Group Inc in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -1.85%
Target price 148.470
Change
Ends at 25.02.27

TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -2.11%
Target price 135.744
Change
Ends at 25.02.27

TransMedics Group (TMDX) had its price target raised by Piper Sandler from $140.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -9.05%
Target price 147.622
Change
Ends at 25.02.27

TransMedics Group (TMDX) had its price target raised by Needham & Company LLC from $166.00 to $174.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more